Search by Drug Name or NDC

    NDC 00904-6463-20 dimaphen dm 2; 10; 5 mg/10mL; mg/10mL; mg/10mL Details

    dimaphen dm 2; 10; 5 mg/10mL; mg/10mL; mg/10mL

    dimaphen dm is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00904-6463
    Product ID 0904-6463_f915e1f8-ea35-4e6f-8b68-68c74af2954f
    Associated GPIs 43995803080910
    GCN Sequence Number 060622
    GCN Sequence Number Description brompheniram/phenylephrine/DM SOLUTION 1-2.5-5/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 26808
    HICL Sequence Number 035368
    HICL Sequence Number Description BROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name dimaphen dm
    Proprietary Name Suffix n/a
    Non-Proprietary Name Brompheniramine maleate, Dextromethorphan HBr, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 2; 10; 5
    Active Ingredient Units mg/10mL; mg/10mL; mg/10mL
    Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Major Pharmaceuticals
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00904-6463-20 (00904646320)

    NDC Package Code 0904-6463-20
    Billing NDC 00904646320
    Package 1 BOTTLE in 1 CARTON (0904-6463-20) / 118 mL in 1 BOTTLE
    Marketing Start Date 2006-09-11
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.01699
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description DIMAPHEN DM ELIXIR
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 67072a38-1ae7-4e59-bfed-71db0d93215d Details

    Revised: 8/2020